Beijing Cairui Pharmaceutical

Beijing Cairui Pharmaceutical is a China-based biopharmaceutical company specializing in the research, development, and industrialization of high-end complex formulations and innovative drugs. The company focuses on long-acting injectable microspheres, liposomes, and inhalation preparations, targeting therapeutic areas such as the central nervous system, oncology, and metabolic diseases. Its lead programs include long-acting microsphere formulations of risperidone and rotigotine designed to improve patient compliance and therapeutic outcomes. Cairui operates a comprehensive R&D center in Beijing and has established large-scale manufacturing capabilities to support its clinical and commercial goals. The company aims to bridge the gap between laboratory innovation and commercial-scale production of complex drug delivery systems.